NSPR (InspireMD, Inc.) Stock Analysis - SEC Filings

InspireMD, Inc. (NSPR) is a publicly traded Healthcare sector company. As of May 21, 2026, NSPR trades at $1.00 with a market cap of $49.18M and a P/E ratio of -1.33. NSPR moved +1.00% today. Year to date, NSPR is -48.19%; over the trailing twelve months it is -54.34%. Its 52-week range spans $0.97 to $3.80. Analyst consensus is strong buy with an average price target of $3.67. Rallies surfaces NSPR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find NSPR SEC filings?

Rallies organizes NSPR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

NSPR Key Metrics

Key financial metrics for NSPR
MetricValue
Price$1.00
Market Cap$49.18M
P/E Ratio-1.33
EPS$-0.76
Dividend Yield0.00%
52-Week High$3.80
52-Week Low$0.97
Volume0
Avg Volume0
Revenue (TTM)$8.98M
Net Income$-48.79M
Gross Margin29.50%

Latest NSPR News

Recent NSPR Insider Trades

  • Slosman Marvin bought 21.00K (~$25.20K) on May 12, 2026.
  • Stuka Paul bought 10.00K (~$11.90K) on May 11, 2026.
  • Stuka Paul bought 10.00K (~$11.90K) on May 11, 2026.

NSPR Analyst Consensus

3 analysts cover NSPR: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $3.67.

Common questions about NSPR

Where can I find NSPR SEC filings?
Rallies organizes NSPR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show NSPR 10-K and 10-Q filings?
Rallies organizes NSPR SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is NSPR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NSPR. It does not provide personalized investment advice.
NSPR

NSPR